VICTORY CAPITAL MANAGEMENT INC

Position in BNTX — BioNTech SE

CIK 1040188 San Antonio, TX

Position in BNTX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$50,227,180

+$7,838,264 QoQ

Shares Held

539,787

+13.2% QoQ

Ownership

0.215%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#18

of 277 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,531,601,071 across 158 Biotechnology names. BNTX ranks #8 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,173,152	$1,079,469,792
2	RPRX	Royalty Pharma plc	3,682,932	$206,501,997
3	INCY	Incyte Corp	1,480,342	$167,811,569
4	JAZZ	Jazz Pharmaceuticals plc	686,719	$165,478,677
5	LGND	Ligand Pharmaceuticals Inc	253,764	$80,212,262
6	REGN	Regeneron Pharmaceuticals, Inc.	126,343	$78,779,914
7	ALNY	Alnylam Pharmaceuticals, Inc.	172,842	$52,030,627
8	BNTX	BioNTech SE This page	539,787	$50,227,180

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$50,227,180	539,787	+13.2%	Shares	Sole	2026-08-07
2026-03-31	$42,388,916	476,923	+19.1%	Shares	Sole	2026-05-15
2025-12-31	$38,136,453	400,593	-3.2%	Shares	Sole	2026-02-13
2025-09-30	$40,797,614	413,685	+97.0%	Shares	Sole	2025-11-12
2025-06-30	$22,357,101	209,985	+7123.4%	Shares	Sole	2025-08-13
2024-09-30	$345,264	2,907	-71.6%	Shares	Sole	2024-11-05
2022-12-31	$1,537,501	10,235	+7.4%	Shares	Sole	2023-04-25
2022-09-30	$1,285,001	9,527	-8.9%	Shares	Sole	2022-11-02
2022-03-31	$1,784,057	10,460	-10.3%	Shares	Sole	2022-05-04
2021-12-31	$3,005,948	11,660	+10.3%	Shares	Sole	2022-02-07
2021-09-30	$2,884,958	10,568	—	Shares	Sole	2021-11-02
No filing history on record for this holder in this stock.